Percutaneous computed tomography/ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck

Cancer Biology and Therapy

Volumn 9, Issue 12, 2010, Pages 959-966

  Jiang, Yu Liang ^a   Na Meng, ^a   Wang, Jun Jie ^a   Ran, Wei Qiang ^a   Yuan, Hui Shu ^a   Qu, Ang ^a   Yang, Rui Jie ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

125I seed implantation; CT; Head and neck; Recurrent squamous cell carcinoma; Ultrasonography

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; DOSIMETRY; DRUG EFFICACY; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEART DISEASE; HUMAN; MALE; METASTASIS; MORBIDITY; PNEUMONIA; RADIOISOTOPE THERAPY; RECURRENT CANCER; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOGRAPHY, INTERVENTIONAL; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77954406434     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.12.11700     Document Type: Article

References (41)

1. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16:1310-7.
2. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation thrapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91:2081-6.
3. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results od a European Organization for Research and Treatment of Cancer Phase III trial. J Natl Cancer Inst 1996; 88:890-9. (Pubitemid 26230640)
4. Forastiere AA, Goepfer H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349:2091-8.
5. Ridge JA. Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence. Semin Oncol 1993; 20:419-29.
6. Marcial VA, Pajak TF, Kramer S, et al. Radiation Oncology group (RTOG) studies in head and neck cancer. Semin Oncol 1998; 15:39-60.
7. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma - Treatment techniques and results. Int J Radiat Oncol Biol Phys 1987; 13:953-6.
8. Shin DM, Khuri FR, Glisson BS, et al. Phase II study of paclitaxel, ifosfamide and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer 2001; 91:1316-23.
9. Harrison LB. Application of brachytherapy in head and neck cancer. Semi Surg Oncol 1997; 13:177-84.
10. Lee DJ, Liberman FZ, Park RI, et al. Intraoperative I-125 seed implantation for extensive recurrent head and neck carcinomas. Radiology 1991; 178:879-82.
11. 192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of bare tongue carcinoma by radiation therapy. Cancer 1985; 55:941-8.
12. Hilaris BS, Lewis JS, Henschke MK. Therapy of recurrent cancer of the nasopharynx. Arch Otolaryngol 1968; 87:506-10.
13. Wang CC, Burse K, Gitterman M. A simple afterloading applicator or intracavitary irradiation of carcinoma of the nasopharynx. Radiology 1975; 115:737-8.
14. Ash D. Interstitial therapy. Acta Radiol 1986; 16:369-93.
15. 125Iodine source in interstitial tumor therapy: Clinical and biological considerations. Am J Roentgenol 1975; 125:163-9.
16. 125I interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1980; 6:1745-9.
17. Cox JD, Stetz J, Pajak TF. The toxicity criteria of the Radiation Therapy Oncology for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31:1341-6.
18. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47:207-14.
19. Kennedy JT, Krause CJ, Loevy S. The importance of tumor attachment to the carotid artery. Arch Otolaryngol Head Neck Surg 1977; 103:70-3. (Pubitemid 8040826)
20. Emami B, Bignardi M, Devineni VR, et al. Re-irradiation of head and neck cancer. Laryngoscope 1987; 97:85-8.
21. Langois D, Eschwege F, Kramer A, et al. Re-irradiation of head and neck cancers. Radiother Oncol 1985; 3:27-33.
22. Pomp J, Levendage PC, van Putten WLJ. Re-irradiation with recurrent tumors in the head and neck. Am J Clin Oncol 1988; 11:543-9.
23. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: Re-irradiation with concurrent hydroxyurea and 5-flurouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001; 51:1299-304.
24. Vokes EE, Haraf DJ, Mick R, et al. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol 1994; 12:2351-9. (Pubitemid 24346707)
25. Hartsell WF, Thomas CR, Murthy AK, et al. Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (ESTPC385). Am J Clin Oncol 1994; 17:338-43.
26. Stevens KR, Britsch A, Moss WT. High-dose re-irradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994; 29:687-98. (Pubitemid 24241307)
27. 192Ir implant. Laryngoscope 1983; 93:1345-7.
28. Mazeron JJ, Langlolis D, Glaubinger D, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 1987; 13:957-62.
29. Puthawala AA, Syed AMN. Interstitial re-irradiation for recurrent and/or persistent head and neck cancers. Int J Radiat Oncol Biol Phys 1987; 13:1113-4.
30. Geiger M, Strnad V, Lotter M, et al. Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and -neck cancer. Brachytherapy 2002; 1:149-53.
31. Strand V, Geiger M, Lotter M, et al. The role of pulseddose-rate brachytherapy in previously irradiated headand- neck cancer. Brachytherapy 2003; 2:158-63. (Pubitemid 37205062)
32. Senan S, Levendage PC. Brachytherapy for recurrent head and neck cancer. Hematol Oncol Clin North Am 1999; 13:531-42.
33. Decroix Y, Ghossein NA. Experience of the Curie Institute in treatment of cancer of the mobile tongue. Cancer 1981; 47:496-502.
34. Hilaris BS. Handbook of interstitial brachytherapy. Acton. MA: Publishing Science Group 1975.
35. Fee WE, Goffinet DR, Paryani S, et al. Intraoperative Iodine-125 implants. Arch Otolaryngol 1983; 109:727-30.
36. Vikram B, Hilaris BS, Anderson L, et al. Permanent iodine-125 implants in head and neck cancer. Cancer 1983; 51:1310-4.
37. Goffinet DR, Martinez A, Fee WE Jr. I-125 vicry suture implants as a surgical adjuvant in cancer of the head and neck. Int J Radiat Oncol Biol Phys 1985; 11:399-402. (Pubitemid 15144209)
38. Park R, Liberman FZ, Lee DJ, et al. Iodine-125 seed implantation as an adjuvant to surgery in advanced recurrent squamous cell cancer of the head and neck. Laryngoscope 1991; 101:405-10.
39. Ashamalla H, Rafla S, Zaki B, et al. Radioactive gold grain implants in recurrent and locally advanced headand-neck cancers. Brachytherapy 2002; 1:161-6.
40. 125Iodine implants as an adjuvant to surgery and external beam radiotherapy in the management of locally advanced head and neck cancer. Cancer 1983; 51:973-9.
41. Krempien RC, Grehn C, Haag C, et al. Feasibility report for retreatment of locally recurrent head-and neck cancers by combined brachytherapy using frameless image-guided 3D interstitial brachytherapy. Brachytherapy 2005; 4:154-62.